Hospital Clínico Universitario de Valencia

Valencia, Valencia 46010

1 studies enrolling now · 9 studies all time

What they study most

Amyloid Cardiomyopathy, Transthyretin-Related, Autosomal Dominant Polycystic Kidney Disease, Carcinoma of the Cervix, Stage IVB, Cervical Carcinoma, Endometrial Carcinoma, Fallopian Tube Carcinoma, Head and Neck Squamous Cell Carcinoma, Lung Cancer Non Small Cell, NASH - Nonalcoholic Steatohepatitis, Ovarian Carcinoma, Primary Peritoneal Carcinoma, Solid Tumor

Studies at this site

• ANCHOR Study: A Study to Assess the Safety and Efficacy of ABBV-CLS-628 in Adult Participants With Autosomal Dominant Polycystic Kidney Disease (ADPKD) — Recruiting now
• Computerized Registry of Patients With Venous Thromboembolism (RIETE) — Recruiting now
• CRF2 Agonist for the Treatment of Worsening Heart Failure — Paused
• A Phase 3 Study Evaluating Efficacy and Safety of Lanifibranor Followed by an Active Treatment Extension in Adult Patients With (NASH) and Fibrosis Stages F2 and F3 ( NATiV3 ) — Running, not enrolling
• Platinum Chemotherapy Plus Paclitaxel With Bevacizumab and Atezolizumab in Metastatic Carcinoma of the Cervix — Completed
• IO102-IO103 in Combination With Pembrolizumab as First-line Treatment for Patients With Metastatic NSCLC, SCCHN, or mUBC — Completed
• Open-Label Safety Study of Acoramidis (AG10) in Symptomatic ATTR Participants — Running, not enrolling
• Study of PYX-106 in Solid Tumors — Running, not enrolling
• Phase 1/2a/3 Evaluation of Adding AL3818 to Standard Platinum-Based Chemotherapy in Subjects With Recurrent or Metastatic Endometrial, Ovarian, Fallopian, Primary Peritoneal or Cervical Carcinoma (AL3818-US-002) — Status unconfirmed